Sign Out
Use of NESP in pregnant women or women who may possibly be pregnant is not recommended. When the use is necessary in such women, it should be limited to cases where expected therapeutic benefits outweigh possible risks associated with the treatment. [The safety of NESP in pregnant women has not been established. Growth retardation in fetuses and offspring has been reported in animal studies (using rats and rabbits).]
Use of NESP in lactating women is not recommended. When the use is necessary in such women, the patients should avoid lactation during the treatment. [The safety of NESP in lactating women has not been established. Its transfer to milk has been reported in animal studies (using rats).]
Continue with Google